Single-fraction 34 Gy Lung Stereotactic Body Radiation Therapy Using Proton Transmission Beams: FLASH-dose Calculations and the Influence of Different Dose-rate Methods and Dose/Dose-rate Thresholds

Favaudon, 2014, Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice, Sci Transl Med, 6, 245, 10.1126/scitranslmed.3008973 Montay-Gruel, 2017, Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose-rates above 100 Gy/s, Radiother Oncol, 124, 365, 10.1016/j.radonc.2017.05.003 Vozenin, 2019, The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients, Clin Cancer Res, 25, 35, 10.1158/1078-0432.CCR-17-3375 Bourhis, 2019, Treatment of a first patient with FLASH-radiotherapy, Radiother Oncol, 139, 18, 10.1016/j.radonc.2019.06.019 Montay-Gruel, 2021, Hypofractionated FLASH-RT as an effective treatment against glioblastoma that reduces neurocognitive side effects in mice, Clin Cancer Res, 27, 775, 10.1158/1078-0432.CCR-20-0894 Ruan, 2021, Irradiation at ultra-high (FLASH) dose rates reduces acute normal tissue toxicity in the mouse gastrointestinal system, Int J Radiat Oncol Biol Phys, 111, 1250, 10.1016/j.ijrobp.2021.08.004 Wilson, 2020, Ultra-high dose rate (FLASH) radiotherapy: Silver bullet or fool's gold?, Front Oncol, 9, 1563, 10.3389/fonc.2019.01563 Hughes, 2020, FLASH radiotherapy: Current knowledge and future insights using proton-beam therapy, Int J Mol Sci, 21, 6492, 10.3390/ijms21186492 Vozenin, 2019, Biological benefits of ultra-high dose rate FLASH radiotherapy: Sleeping beauty awoken, Clin Oncol, 31, 407, 10.1016/j.clon.2019.04.001 Benedict, 2010, Stereotactic body radiation therapy: The report of AAPM Task Group 101, Med Phys, 37, 4078, 10.1118/1.3438081 Guckenberger, 2017, ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer, Radiother Oncol, 124, 11, 10.1016/j.radonc.2017.05.012 Postmus, 2017, Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 28, iv1, 10.1093/annonc/mdx222 Stephans, 2018, Tumor control and toxicity for common stereotactic body radiation therapy dose-fractionation regimens in stage I non-small cell lung cancer, Int J Radiat Oncol Biol Phys, 100, 462, 10.1016/j.ijrobp.2017.10.037 Wrona, 2021, Effect of tumor location and dosimetric predictors for chest wall toxicity in single-fraction stereotactic body radiation therapy for stage I non-small cell lung cancer, Semin Radiat Oncol, 31, 97, 10.1016/j.semradonc.2020.11.003 Whyte, 2003, Stereotactic radiosurgery for lung tumors: Preliminary report of phase I trial, Ann Thorac Surg, 75, 1097, 10.1016/S0003-4975(02)04681-7 Le, 2006, Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors, J Thorac Oncol, 1, 802, 10.1097/01243894-200610000-00008 Fritz, 2006, Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases, Radiat Oncol, 1, 30, 10.1186/1748-717X-1-30 Singh, 2019, One versus three fractions of stereotactic body radiation therapy for peripheral stage Ito II non-small cell lung cancer: A randomized, multi-institution, phase 2 trial, Int J Radiat Oncol Biol Phys, 105, 752, 10.1016/j.ijrobp.2019.08.019 Videtic, 2015, NRG oncology RTCOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer, Int J Radiat Oncol Biol Phys, 93, 757, 10.1016/j.ijrobp.2015.07.2260 Videtic, 2019, Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer, Int J Radiat Oncol Biol Phys, 103, 1077, 10.1016/j.ijrobp.2018.11.051 Dahele, 2011, Radiological changes after stereotactic radiotherapy for stage I lung cancer, J Thorac Oncol, 6, 1221, 10.1097/JTO.0b013e318219aac5 Dahele, 2015, Parenchymal lung changes on computed tomography after stereotactic radiotherapy using high dose rate flattening filter free beams, Radiother Oncol, 114, 357, 10.1016/j.radonc.2015.02.012 Palma, 2019, Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomized, phase 2, open-label trial, Lancet, 393, 2051, 10.1016/S0140-6736(18)32487-5 Olson, 2019, Quality of life outcomes after stereotactic ablative radiation therapy (SABR) versus standard of care treatments in the oligometastatic setting: A secondary analysis of the SABR-COMET randomized trial, Int J Radiation Oncol Biol Phys, 105, 943, 10.1016/j.ijrobp.2019.08.041 Palma, 2020, Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: Long-term results of the SABR-COMET phase II randomized trial, J Clin Oncol, 38, 2830, 10.1200/JCO.20.00818 Montay-Gruel, 2018, X-rays can trigger the FLASH effect: Ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice, Radiother Oncol, 129, 582, 10.1016/j.radonc.2018.08.016 Diffenderfer, 2020, Design, implementation, and in vivo validation of a novel proton FLASH radiation therapy system, Int J Radiat Oncol Biol Phys, 106, 440, 10.1016/j.ijrobp.2019.10.049 Darafsheh, 2020, Feasibility of proton FLASH irradiation using a synchrocyclotron for preclinical studies, Med Phys, 47, 4348, 10.1002/mp.14253 van Marlen, 2020, Bringing FLASH to the clinic: Treatment planning considerations for ultrahigh dose-rate proton beams, Int J Radiat Oncol Biol Phys, 106, 621, 10.1016/j.ijrobp.2019.11.011 Perez, 2019, FLASH radiotherapy: A look at ultra-high dose rate research and treatment plans, Abstract PTCOG Mou, 2014, Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: A dosimetric and feasibility study, PLoS One, 9, e98621, 10.1371/journal.pone.0098621 van Marlen, 2021, Ultra-high dose rate transmission beam proton therapy for conventionally fractionated head and neck cancer: Treatment planning and dose-rate distributions, Cancers, 13, 1859, 10.3390/cancers13081859 FAST-01 FLASH therapy trial. Available at: https://clinicaltrials.gov/ct2/show/NCT04592887. Accessed May 2, 2022. Kang, 2021, Qualitative assessment of 3D dose rate for proton pencil beam scanning FLASH radiotherapy and its application for lung hypofractionation treatment planning, Cancers, 13, 3549, 10.3390/cancers13143549 Folkerts, 2020, A framework for defining FLASH dose rate for pencil beam scanning, Med Phys, 47, 6396, 10.1002/mp.14456 van de Water, 2019, Towards FLASH proton therapy: The impact of treatment planning and machine characteristics on achievable dose rates, Acta Oncol, 58, 1463, 10.1080/0284186X.2019.1627416 Safai, 2012, Improving the precision and performance of proton pencil beam scanning, Translat Cancer Res, 1, 196 Bula, 2019, Dynamic beam current control for improved dose accuracy in PBS proton therapy, Phys Med Biol, 64, 10.1088/1361-6560/ab3317 Pedroni E. Proton beam delivery technique and commissioning issues: Scanned protons. Educational meeting PTCOG 2008. Jin, 2020, Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?, Radiother Oncol, 6, 55, 10.1016/j.radonc.2020.04.054 Spitz, 2019, An integrated physico-chemical approach for explaining the differential impact of FLASH versus conventional dose rate irradiation on cancer and normal tissue responses, Radiother Oncol, 139, 23, 10.1016/j.radonc.2019.03.028 Adrian, 2019, The FLASH effect depends on oxygen concentration, Br J Radiol, 92 Petersson, 2020, A quantitative analysis of the role of oxygen tension in FLASH radiotherapy, Int J Radiat Oncol Biol Phys, 107, 539, 10.1016/j.ijrobp.2020.02.634 Zhou, 2020, Minimum dose rate estimation for pulsed FLASH radiotherapy: A dimensional analysis, Med Phys, 47, 3243, 10.1002/mp.14181 Rothwell, 2021, Determining the parameter space for effective oxygen depletion for FLASH radiation therapy, Phys Med Biol, 66, 10.1088/1361-6560/abe2ea Chabi, 2021, Ultra-high-dose-rate FLASH and conventional-dose-rate irradiation differentially affect human acute lymphoblastic leukemia and normal hematopoiesis, Int J Radiat Oncol Biol Phys, 109, 819, 10.1016/j.ijrobp.2020.10.012 Nicosia, 2019, Long term results of single high dose stereotactic body radiotherapy in the treatment of primary lung tumors, Sci Rep, 9, 15498, 10.1038/s41598-019-51900-8 Kalinauskaite, 2020, Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases, BMC Cancer, 20, 404, 10.1186/s12885-020-06892-4 Krieger, 2022, A quantitative FLASH effectiveness model to reveal potentials and pitfalls of high dose rate proton therapy, Med Phys, 49, 2026, 10.1002/mp.15459 Palma, 2019, Stereotactic ablative radiotherapy for the comprehensive treatment 4-10 oligometastatic tumors (SABR-COMET-10): Study protocol for a randomized phase III trial, BMC Cancer, 19, 816, 10.1186/s12885-019-5977-6 Hazelaar, 2018, Markerless positional verification using template matching and triangulation of kV images acquired during irradiation for lung tumors treated in breath-hold, Phys Med Biol, 63, 10.1088/1361-6560/aac1a9 Remmerts de Vries, 2021, Markerless 3D tumor tracking during single-fraction free-breathing 10MV flattening-filter-free stereotactic lung radiotherapy, Radiother Oncol, 164, 6, 10.1016/j.radonc.2021.08.025 Kang, 2022, A universal range shifter and range compensator can enable proton pencil beam scanning single-energy Bragg peak FLASH-RT treatment using current commercially available proton systems, Int J Radiat Oncol Biol Phys, 113, 203, 10.1016/j.ijrobp.2022.01.009 Böhlen, 2021, Characteristics of very high-energy electron beams for the irradiation of deep-seated targets, Med Phys, 48, 3958, 10.1002/mp.14891 Whitmore, 2021, Focused VHEE (very high energy electron) beams and dose delivery for radiotherapy applications, Sci Rep, 11, 14013, 10.1038/s41598-021-93276-8